Breast cancer: FDA okays direct-to-consumer test that reports three mutations in the BRCA breast cancer genes

The U.S. Food and Drug Administration this week authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected Variants). It is the first direct-to-consumer (DTC) test to report More...